Resultados de la búsqueda 1-10 of 40493 for breast

1. Clínica de las mamas - Ensayos clínicos - Mayo Clinic

   ... breast conditions. Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer. Scottsdale/Phoenix, Ariz. The purpose of this study is to ...

2. Clínica de las mamas - Ensayos clínicos - Mayo Clinic

   ... breast conditions. Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer. Scottsdale/Phoenix, Ariz. The purpose of this study is to ...

3. Clínica de las mamas - Ensayos clínicos - Mayo Clinic

   Collection of tissue and blood from patients with residual disease after neoadjuvant systemic therapy for breast cancer. We hope to use these samples to ...

4. Clínica de las mamas - Ensayos clínicos - Mayo Clinic

   Many breast cancer survivors report cancer-related cognitive impairment, which this has recently become a priority in clinical research due to its dramatic ...

5. Cáncer de mama - Síntomas y causas - Mayo Clinic

   Breast Cancer Discussions. mjay · Lobular Breast Cancer: Let's share and support each other. 580 Replies Sun, Apr 05, 2026.

6. Clínica de las mamas - Ensayos clínicos - Mayo Clinic

   ... breast conditions. Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer. Scottsdale/Phoenix, Ariz. The purpose of this study is to ...

7. Clínica de las mamas - Ensayos clínicos - Mayo Clinic

   ... breast conditions. Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer. Scottsdale/Phoenix, Ariz. The purpose of this study is to ...

8. Clínica de las mamas - Ensayos clínicos - Mayo Clinic

   The purpose of this study is to identify subtype-specific signatures for breast cancer using genomic positioning of plasma DNA fragments, and to validate ...

9. Clínica de las mamas - Ensayos clínicos - Mayo Clinic

   placebo in combination with ado-trastuzumab emtansine (TTT-DM1) in patients with stage II-III HER2+ breast cancer with residual disease post-neoadjuvant ...

10. Clínica de las mamas - Ensayos clínicos - Mayo Clinic

    placebo in combination with ado-trastuzumab emtansine (TTT-DM1) in patients with stage II-III HER2+ breast cancer with residual disease post-neoadjuvant ...